Inogen Inc  

(Public, NASDAQ:INGN)   Watch this stock  
Find more results for INGN
37.34
-0.39 (-1.03%)
May 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 36.75 - 37.95
52 week 15.81 - 40.80
Open 37.50
Vol / Avg. 288,577.00/189,050.00
Mkt cap 723.84M
P/E 92.61
Div/yield     -
EPS 0.40
Shares 19.28M
Beta     -
Inst. own 96%
Aug 10, 2015
Q2 2015 Inogen Inc Earnings Release (Estimated) Add to calendar
May 12, 2015
Q1 2015 Inogen Inc Earnings Call
May 12, 2015
Q1 2015 Inogen Inc Earnings Release
Apr 27, 2015
Q4 2014 Inogen Inc Earnings Release
Apr 27, 2015
Q4 2014 Inogen Inc Earnings Call
Apr 15, 2015
Inogen Inc at Needham Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.66% 6.07%
Operating margin 7.46% 9.34%
EBITD margin - 20.07%
Return on average assets 4.37% 6.14%
Return on average equity 5.24% 18.99%
Employees 411 -
CDP Score - -

Address

326 Bollay Drive
GOLETA, CA 93117
United States - Map
+1-805-5620500 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Inogen, Inc. (Inogen) is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems for the patients who require long-term oxygen therapy. The Company offers Inogen One systems for the patients who require long-term oxygen therapy. The Company’s products include Inogen One G3 and Inogen One G2. The Inogen One G3 and Inogen One G2, weighs at approximately 4.8 and 7.0 pounds, respectively, are amongst the most lightweight portable oxygen concentrators. Its product offerings include the Inogen One G3 and the Inogen One G2, as single solutions for oxygen therapy. One G2 is effective for nocturnal use. Its Inogen One G2 and the Inogen One G3 are sub-5 and sub-10 pound portable oxygen.

Officers and directors

Heath Lukatch Ph.D. Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
Raymond O. Huggenberger President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Alison Bauerlein Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
Age: 33
Bio & Compensation  - Reuters
Scott Wilkinson Executive Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Matthew Scribner Executive Vice President - Operations
Age: 47
Bio & Compensation  - Reuters
Brenton Taylor Executive Vice President - Engineering
Age: 33
Bio & Compensation  - Reuters
Byron Myers Vice President - Marketing
Age: 35
Bio & Compensation  - Reuters
Heather D. Rider Director
Age: 55
Bio & Compensation  - Reuters
Benjamin M. Anderson-Ray Independent Director
Age: 59
Bio & Compensation  - Reuters
Loren L. McFarland Independent Director
Age: 55
Bio & Compensation  - Reuters